Genital Herpes

NanoBio To Present Data On Herpes, RSV VaccinesNanoBio Corp. announced the company will present new data at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy meeting showing the safety and effectiveness of a vaccine for the prevention of respiratory syncytial virus, enhanced by the company's nanoemulsion technology.
NanoBio Closes $11 Million Series C FinancingNanoBio Corp. announced Wednesday the closing of an $11 million Series C financing, including full participation from its existing investor syndicate.
Best Winter Festivals In Metro Detroit
Thanksgiving Parade Guide

Watch & Listen